Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 18, 2023
Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: Results from the Ontario Neurodegenerative Disease Research InitiativeErlan Sanchez, Tim Wilkinson, Gillian Coughlan, et al.
Neurobiology of Aging|May 27, 2021
Association of apolipoprotein E variation with cognitive impairment across multiple neurodegenerative diagnosesAllison A Dilliott, Kelly M Sunderland, Paula M McLaughlin, et al.
Seminars in Arthritis and Rheumatism|April 24, 2021
Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approachKarine Toupin-April, Simon Décary, Maarten de Wit, et al.
Seminars in Arthritis and Rheumatism|February 2, 2024
Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trialsSimon Décary, Maarten de Wit, Florian Naye, et al.
Geroscience|March 16, 2022
Investigating the contribution of white matter hyperintensities and cortical thickness to empathy in neurodegenerative and cerebrovascular diseasesMiracle Ozzoude, Brenda Varriano, Derek Beaton, et al.
Alzheimer'S Research & Therapy|June 20, 2023
White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseasesMiracle Ozzoude, Brenda Varriano, Derek Beaton, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trialStephen Macfarlane, Timo Grimmer, Ken Teo, et al.
Neurology|March 10, 2025
Association of Plasma Biomarkers With Longitudinal Atrophy and Microvascular Burden on MRI Across Neurodegenerative and Cerebrovascular DiseasesErlan Sanchez, Gillian T Coughlan, Tim Wilkinson, et al.
The Journal of Prevention of Alzheimer'S Disease|February 1, 2025
Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future researchEric E Smith, Natalie A Phillips, Howard H Feldman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 1, 2022
Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohortKelly M Sunderland, Derek Beaton, Stephen R Arnott, et al.
Pageof 11